Atogepant

What is Atogepant?

• Atogepant (Qulipta) is a calcitonin gene-related peptide receptor antagonist used to prevent episodic migraines.

File:Atogepant.svg

Atogepant

File:Atogepant v.01.svg

Atogepant v.01

What are the uses of this medicine?

• Atogepant (Qulipta) is a prescription medicine used for the preventive treatment of episodic migraine in adults.

How does this medicine work?

• Atogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist.

Who Should Not Use this medicine ?

• This medicine have no usage limitations.

What drug interactions can this medicine cause?

• QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.
• Especially tell your healthcare provider if you take any of the following, as your healthcare provider may need to change the dose of QULIPTA:
• ketoconazole or itraconazole
• rifampin
• St. John’s wort
• cyclosporine
• carbamazepine
• efavirenz
• clarithromycin
• phenytoin
• etravirine

Is this medicine FDA approved?

• It was approved for medical use in the United States in September 2021.

How should this medicine be used?

Recommended dosage:

• The recommended dosage of QULIPTA is 10 mg, 30 mg, or 60 mg taken orally once daily with or without food.
• Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.

Administration:

• Take QULIPTA by mouth 1 time each day with or without food.
• Take QULIPTA exactly as your healthcare provider tells you to take it.

What are the dosage forms and brand names of this medicine?

This medicine is available in fallowing doasage form:

• As Tablets: 10 mg, 30 mg, and 60 mg.

This medicine is available in fallowing brand namesː

• QULIPTA

What side effects can this medication cause?

The most common side effects of this medicine include:

• nausea
• constipation
• fatigue

What special precautions should I follow?

• Inform patients that QULIPTA may interact with certain other drugs, and that dosage modifications of QULIPTA may be recommended when used with some other drugs.
• Advise patients to report to their healthcare provider the use of any other prescription medications, over-the-counter medications, herbal products, or grapefruit juice.

What to do in case of emergency/overdose?

• In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

• Overdose related information is also available online at poisonhelp.org/help.
• In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.

Can this medicine be used in pregnancy?

• There are no adequate data on the developmental risk associated with the use of QULIPTA in pregnant women.
• It is not known if QULIPTA will harm your unborn baby.

Can this medicine be used in children?

• It is not known if QULIPTA is safe and effective in children.

What are the active and inactive ingredients in this medicine?

• Active ingredient: atogepant
• Inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, mannitol, microcrystalline cellulose, polyvinylpyrrolidone vinyl acetate copolymer, sodium chloride, sodium stearyl fumarate, and vitamin E polyethylene glycol succinate.

Who manufactures and distributes this medicine?

Manufactured by:

• Forest Laboratories Ireland Ltd.
• Dublin, Ireland

What should I know about storage and disposal of this medication?

• Store QULIPTA at room temperature between 68ºF to 77ºF (20ºC to 25ºC).

• Dailymed label info on Atogepant
• FDA Atogepant

File:Paracetamol-3D-vdW.png

This analgesic-related article is a stub. You can help WikiMD by expanding it.